Atorvastatin Calcium Clinical Trials 
This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.
This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.A Study to Evaluate the Efficacy and Safety of BR1017A and BR1017B Combination Therapy in Essential Hypertension Patients With Primary Hypercholesterolemia
Conditions: Essential Hypertension; Primary Hypercholesterolemia Interventions: Drug: Fimasartan; Drug: Ezetimibe/Atorvastatin; Drug: Fimasartan Placebo; Drug: Ezetimibe/Atorvastatin Placebo Sponsor: Boryung Pharmaceutical Co., Ltd Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - July 5, 2023 Category: Research Source Type: clinical trials
